GILEAD SCIENCES $55.93

down -0.54


22/5/2013 04:22 PM  |  NASDAQ : GILD  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 55.93
Trade Time: May 22 4:04 PM Eastern Daylight Time
Change: -0.54 (-0.96 %)
Prev Close: 56.47
Open: 57.00
Bid: 55.91
Ask: 56.17
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing GILD also viewed: , , , ,

Competitors

Ticker Name Volume % Change
IXSBF INNEXUS BIOTECHNOLOGY 250.0K +2.00%
BMCS BIOTECH MEDICS 400.0 +1.53%
INGNQ INTROGEN THERAPEUTICS 10.0K +1.10%
GVBP GENOVA BIOTHERAPEUTICS 3.5K +1.00%
ALLP ALLIANCE PHARMACEUTICAL 166.2K +0.55%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/10/2013 DAVIGNON ETIENNE Director -1,756 $52.88 -0.15%
5/1/2013 Alton Gregg H EVP, Corp & Med Affairs -30,000 $50.20 -31.94%
5/1/2013 Alton Gregg H EVP, Corp & Med Affairs 26,000 $16.40 38.27%
5/1/2013 MARTIN JOHN C Chairman and CEO 282,242 $7.63 6.96%
5/1/2013 MARTIN JOHN C Chairman and CEO -282,242 $50.17 -6.50%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (GILD), click here.
View All

GILD Stock Analysis

  1. Roche, Reloaded

    (RHHBY,BMY,GILD,MRK,JNJ )
    Roche has one of the best long-term growth profiles in the Big Pharma space
  2.

    Amgen Chased By The Bubble

    (AMGN,PFE,SNY,TEVA,CELG,NVO,MRK,HSP,ABT,AFFY,BIIB,GILD )
    Amgen really needs the pipeline to come through to support this valuation.
Free Reports
  1.

    Free Investment Report: 6 Must-Own Emerging Market Stocks

    Gain Valuable Insights into International and Emerging Markets That are Poised for Explosive Growth!
  2.

    Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  3.

    Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
Marketplace
Trading Center